Funding momentum Recovery Force has secured substantial funding and grants (15M total funding with notable NIH support and a 10M angel investment) signaling validated market potential and capacity for rapid expansion and production scale.

Clinical validation Strong collaboration history with Mayo Clinic and NIH funding for clinical development of the Mobile Active Compressions calf device suggests a credibility boost for hospital and clinical partnerships, easing entry for B2B sales to larger healthcare networks.

Manufacturing partners Existing manufacturing relationship with Jabil, chosen for textile and electronics expertise, indicates a capable supply chain; further opportunities exist to expand contract manufacturing or co-development with similar tiered partners to scale production.

Product traction Flagship MAC calf device targets mobility and circulation, aligning with hospital mobility initiatives and at-home recovery trends; potential upsell through complementary wearables, accessories, and data-collection services for post-acute care.

Market positioning Midwest-based startup with a lean headcount but growing revenue and investor interest presents a pathway for regional partnerships with health systems, distributors, and OEMs seeking innovative, clinically validated medical wearables.